Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 07    source : Www.zynerba.com    save search
Zynerba Pharmaceuticals Announces Publication of Results of Phase 2 BELIEVE Open-Label Study of Zygel™ in Children and Adolescents with Developmental and Epileptic Encephalopathies (DEE) in JAMA Network Open
Published: 2021-09-07 (Crawled : 11:00) - zynerba.com
ZYNE | $1.3 3.08% 860K twitter stocktwits trandingview |
Health Technology
 | | O: -1.11% H: 3.14% C: 0.0%
phase 2 results children zygel
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.